Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Open Access
- 6 February 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (2) , 217
Abstract
The discovery and development of new pharmaceutical drugs is a costly, time-consuming, and highly manual process, with significant challenges in ensuring drug bioavailability at target sites. Computational techniques are highly employed in drug design, particularly to predict the pharmacokinetic properties of molecules. One major kinetic challenge in central nervous system drug development is the permeation through the blood–brain barrier (BBB). Several different computational techniques are used to evaluate both BBB permeability and target delivery. Methods such as quantitative structure–activity relationships, machine learning models, molecular dynamics simulations, end-point free energy calculations, or transporter models have pros and cons for drug development, all contributing to a better understanding of a specific characteristic. Additionally, the design (assisted or not by computers) of prodrug and nanoparticle-based drug delivery systems can enhance BBB permeability by leveraging enzymatic activation and transporter-mediated uptake. Neuroactive peptide computational development is also a relevant field in drug design, since biopharmaceuticals are on the edge of drug discovery. By integrating these computational and formulation-based strategies, researchers can enhance the rational design of BBB-permeable drugs while minimizing off-target effects. This review is valuable for understanding BBB selectivity principles and the latest in silico and nanotechnological approaches for improving CNS drug delivery.Keywords
Funding Information
- FAPDF (39828.204.31613.06052024, 00193-0000001859/2023-84, 00193-00001265/2021-10, 403543/2021-5, 309671/2023-0, 001)
- CNPq (39828.204.31613.06052024, 00193-0000001859/2023-84, 00193-00001265/2021-10, 403543/2021-5, 309671/2023-0, 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES) (39828.204.31613.06052024, 00193-0000001859/2023-84, 00193-00001265/2021-10, 403543/2021-5, 309671/2023-0, 001)
- University of Brasilia (39828.204.31613.06052024, 00193-0000001859/2023-84, 00193-00001265/2021-10, 403543/2021-5, 309671/2023-0, 001)
This publication has 146 references indexed in Scilit:
- A comparison between 2D and 3D descriptors in QSAR modeling based on bio‐active conformationsMolecular Informatics, 2023
- Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and ChallengesAdvanced Science, 2021
- Protein Chemical Synthesis Combined with Mirror‐Image Phage Display Yields d‐Peptide EGF Ligands that Block the EGF–EGFR InteractionChemBioChem, 2019
- In Silico Prediction of Blood–Brain Barrier Permeability of Compounds by Machine Learning and Resampling MethodsChemMedChem, 2018
- A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small MoleculesChemMedChem, 2016
- Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer ImmunotherapyAngewandte Chemie International Edition, 2015
- Towards Better BBB Passage Prediction Using an Extensive and Curated Data SetMolecular Informatics, 2015
- Quantitative Structure‐Toxicity Models for Heterogeneous Aliphatic CompoundsQSAR & Combinatorial Science, 2009
- Artificial Neural Networks in ADMET Modeling: Prediction of Blood–Brain Barrier PermeationQSAR & Combinatorial Science, 2008
- Selection of D‐Amino‐Acid Peptides That Bind to Alzheimer's Disease Amyloid Peptide Aβ1–42 by Mirror Image Phage DisplayChemBioChem, 2003